RBC Financial Statements From 2010 to 2026

RBCL Stock  USD 0.0004  0.00  0.00%   
RBC Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing RBC Life's valuation are provided below:
RBC Life Sciences does not right now have any fundamental measures for analysis.
Check RBC Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RBC Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . RBC financial statements analysis is a perfect complement when working with RBC Life Valuation or Volatility modules.
  
This module can also supplement various RBC Life Technical models . Check out the analysis of RBC Life Correlation against competitors.

RBC Life Sciences Company Return On Equity Analysis

RBC Life's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current RBC Life Return On Equity

    
  -0.0677  
Most of RBC Life's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RBC Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, RBC Life Sciences has a Return On Equity of -0.0677. This is 102.56% lower than that of the Personal Products sector and 100.46% lower than that of the Consumer Staples industry. The return on equity for all United States stocks is 78.16% lower than that of the firm.

RBC Life Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining RBC Life's current stock value. Our valuation model uses many indicators to compare RBC Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RBC Life competition to find correlations between indicators driving RBC Life's intrinsic value. More Info.
RBC Life Sciences is currently regarded as top stock in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RBC Life's earnings, one of the primary drivers of an investment's value.

About RBC Life Financial Statements

RBC Life investors utilize fundamental indicators, such as revenue or net income, to predict how RBC Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company was founded in 1988 and is headquartered in Irving, Texas. RBC Life operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 89 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

Other Information on Investing in RBC Pink Sheet

RBC Life financial ratios help investors to determine whether RBC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Life security.